137 related articles for article (PubMed ID: 30179137)
1. Is there a Role for Sodium Orthovanadate in the Treatment of Diabetes?
Rana D; Kumar A
Curr Diabetes Rev; 2019; 15(4):284-287. PubMed ID: 30179137
[TBL] [Abstract][Full Text] [Related]
2. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
3. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
[TBL] [Abstract][Full Text] [Related]
4. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Darji B; Siriki Y; Bandyopadhyay D; Joharapurkar A; Kshirsagar S; Patel H; Shaikh M; Sairam KV; Patel P
ChemMedChem; 2011 Jun; 6(6):1011-6. PubMed ID: 21506278
[No Abstract] [Full Text] [Related]
5. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of hyperhomocysteinemia induced vascular dementia by sodium orthovanadate perhaps via PTP1B: Pertinent downstream outcomes.
Kumar S; Ivanov S; Lagunin A; Goel RK
Behav Brain Res; 2019 May; 364():29-40. PubMed ID: 30721761
[TBL] [Abstract][Full Text] [Related]
9. An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors.
Bibi S; Sakata K
Curr Comput Aided Drug Des; 2017 Nov; 13(4):319-335. PubMed ID: 28382867
[TBL] [Abstract][Full Text] [Related]
10. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
11. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors.
Ezzat SM; Bishbishy MHE; Habtemariam S; Salehi B; Sharifi-Rad M; Martins N; Sharifi-Rad J
Molecules; 2018 Dec; 23(12):. PubMed ID: 30558294
[TBL] [Abstract][Full Text] [Related]
12. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
13. Current anti-diabetic agents and their molecular targets: A review.
Kerru N; Singh-Pillay A; Awolade P; Singh P
Eur J Med Chem; 2018 May; 152():436-488. PubMed ID: 29751237
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
Verma M; Gupta SJ; Chaudhary A; Garg VK
Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
Kousaxidis A; Petrou A; Lavrentaki V; Fesatidou M; Nicolaou I; Geronikaki A
Eur J Med Chem; 2020 Dec; 207():112742. PubMed ID: 32871344
[TBL] [Abstract][Full Text] [Related]
16. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
18. In the Search of Glycoside-Based Molecules as Antidiabetic Agents.
Pałasz A; Cież D; Trzewik B; Miszczak K; Tynor G; Bazan B
Top Curr Chem (Cham); 2019 Jun; 377(4):19. PubMed ID: 31165274
[TBL] [Abstract][Full Text] [Related]
19. Growth factor-stimulated protein synthesis is inhibited by sodium orthovanadate.
Viñals F; McKenzie FR; Pouysségur J
Eur J Biochem; 2001 Apr; 268(8):2308-14. PubMed ID: 11298748
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphorylation in signalling pathways leading to the activation of gelatinase A: activation of gelatinase A by treatment with the protein tyrosine phosphatase inhibitor sodium orthovanadate.
Li L; Eisen AZ; Sturman E; Seltzer JL
Biochim Biophys Acta; 1998 Oct; 1405(1-3):110-20. PubMed ID: 9784619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
